Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease

BACKGROUND & AIMS: Some women with inflammatory bowel disease (IBD) require therapy with tumor necrosis factor (TNF) antagonists during pregnancy. It is not clear whether these drugs are transferred to the fetus, via the placenta, and then cleared, or whether structurally different TNF antagonis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mahadevan, Uma, Wolf, Douglas C., Dubinsky, Marla, Cortot, Antoine, Lee, Scott D., Siegel, Corey A., Ullman, Thomas, Glover, Sarah, Valentine, John F., Rubin, David T., Miller, Jocelyn, Abreu, Maria T.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913646/
https://ncbi.nlm.nih.gov/pubmed/23200982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2012.11.011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items